Immediate Impact
8 standout
Citing Papers
Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials
2023 Standout
Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status — United States, April 2021–September 2022
2023 Standout
Works of Daniel Soranz being referenced
Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: a test-negative design study
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniel Soranz | 210 | 57 | 32 | 61 | 26 | 307 | |
| Alexandre Medeiros de Figueiredo | 183 | 61 | 37 | 40 | 25 | 343 | |
| Juliana Gagno Lima | 272 | 31 | 20 | 64 | 19 | 340 | |
| Kanang Kantamaturapoj | 126 | 47 | 21 | 49 | 20 | 344 | |
| Nareerut Pudpong | 101 | 28 | 26 | 63 | 30 | 280 | |
| Kirill Danishevski | 139 | 66 | 40 | 61 | 16 | 355 | |
| Leonardo Ferreira Fontenelle | 143 | 35 | 18 | 27 | 29 | 329 | |
| Pempelani Mufune | 148 | 39 | 56 | 35 | 27 | 315 | |
| Kausar S Khan | 162 | 54 | 14 | 56 | 30 | 360 | |
| Moslem Soofi | 116 | 74 | 14 | 75 | 40 | 350 | |
| Eleanor Whyle | 122 | 58 | 23 | 61 | 21 | 304 |
All Works
Login with ORCID to disown or claim papers
Loading papers...